Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBridge Biosciences (NBP) Short-term Investments (2018 - 2022)

NovaBridge Biosciences (NBP) has disclosed Short-term Investments for 5 consecutive years, with $33.1 million as the latest value for Q4 2022.

  • Quarterly Short-term Investments fell 71.9% to $33.1 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $33.1 million through Dec 2022, down 71.9% year-over-year, with the annual reading at $34.1 million for FY2022, 71.12% down from the prior year.
  • Short-term Investments for Q4 2022 was $33.1 million at NovaBridge Biosciences, down from $117.8 million in the prior quarter.
  • The five-year high for Short-term Investments was $117.8 million in Q4 2021, with the low at $4.8 million in Q4 2020.
  • Average Short-term Investments over 5 years is $35.4 million, with a median of $13.4 million recorded in 2018.
  • The sharpest move saw Short-term Investments soared 2376.05% in 2021, then crashed 71.9% in 2022.
  • Over 5 years, Short-term Investments stood at $13.4 million in 2018, then plummeted by 40.91% to $7.9 million in 2019, then tumbled by 39.92% to $4.8 million in 2020, then skyrocketed by 2376.05% to $117.8 million in 2021, then crashed by 71.9% to $33.1 million in 2022.
  • According to Business Quant data, Short-term Investments over the past three periods came in at $33.1 million, $117.8 million, and $4.8 million for Q4 2022, Q4 2021, and Q4 2020 respectively.